| scholarly article | Q13442814 |
| P50 | author | Mariano Sánchez Crespo | Q43432576 |
| P2093 | author name string | V Furió | |
| A A Steil | |||
| M I Pellón | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731 | Q28573792 | ||
| Role of complement-derived peptides in thrombocytopenia elicited by soluble aggregates of immunoglobulin G in the rat. | Q33432120 | ||
| Shock and tissue injury induced by recombinant human cachectin | Q34189904 | ||
| Augmentation of reverse arthus reaction by mast cells in mice | Q34197650 | ||
| Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate | Q34543432 | ||
| Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice | Q34571151 | ||
| Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor | Q35587409 | ||
| Endotoxin-induced shock in the rat. A role for C5a | Q35816751 | ||
| Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury | Q35856557 | ||
| Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes | Q36347053 | ||
| Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5). | Q36355753 | ||
| Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response | Q36359254 | ||
| Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice | Q37483872 | ||
| Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021. | Q41390696 | ||
| Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis | Q42051045 | ||
| Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell | Q42174196 | ||
| Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin | Q42577082 | ||
| The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis | Q42710783 | ||
| Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells | Q42823862 | ||
| Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice | Q42940138 | ||
| Fc receptors | Q44298973 | ||
| L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor | Q45227226 | ||
| PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis. | Q50800810 | ||
| Role of leukotrienes in vascular changes in the rat mesentery and skin in anaphylaxis | Q50896869 | ||
| Anaphylactic release of mucosal mast cell protease and its relationship to gut permeability in Nippostrongylus-primed rats | Q50923101 | ||
| Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. | Q50924766 | ||
| Anaphylactic shock in the albino rat. | Q53686928 | ||
| Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. | Q54319446 | ||
| Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. | Q54519052 | ||
| Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl)cyanomethyl)piperazines as PAF antagonists. | Q54650028 | ||
| Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions | Q60628599 | ||
| Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization | Q61140921 | ||
| Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether | Q62083825 | ||
| Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions | Q67494107 | ||
| Interaction between IgE complexes and macrophages in the rat: a new mechanism of macrophage activation | Q67585747 | ||
| Mast cell mediators regulate vascular permeability changes in Arthus reaction | Q67901381 | ||
| Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with | Q67932208 | ||
| Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells | Q67996968 | ||
| Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor | Q68238297 | ||
| Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell | Q68419135 | ||
| 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies | Q68480376 | ||
| Gut mucosal mast cells in Nippostrongylus-primed rats are the major source of secreted rat mast cell protease II following systemic anaphylaxis | Q68864977 | ||
| Cardiac anaphylaxis. Complement activation as an amplification system | Q69094051 | ||
| Enteral and systemic release of leukotrienes during anaphylaxis of Nippostrongylus brasiliensis-primed rats | Q70140432 | ||
| Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice | Q70232490 | ||
| Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells | Q70232509 | ||
| Systemic release of mucosal mast-cell protease in primed rats challenged with Nippostrongylus brasiliensis | Q70263118 | ||
| Contribution of macrophages to immediate hypersensitivity reaction | Q70302627 | ||
| Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids | Q71767290 | ||
| Prostaglandins inhibit inflammatory mediator release from rat mast cells | Q72067350 | ||
| Standardization of hemoglobinometry II. The hemiglobincyanide method | Q78943139 | ||
| Intestinal lesions following histamine liberation in the rat | Q79385543 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anaphylaxis | Q168800 |
| P304 | page(s) | 1101-1108 | |
| P577 | publication date | 1994-08-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis | |
| P478 | volume | 112 |
| Q35578791 | Anaphylactoid Reaction from IV Contrast Dye Causing Ischemic Colitis with Portal Venous Gas. |
| Q33387265 | Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor |
| Q42435926 | Nitric oxide decreases intestinal haemorrhagic lesions in rat anaphylaxis independently of mast cell activation. |
| Q42094954 | Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin |
| Q36678654 | Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis |
| Q85570312 | Protective effects of Yangambin - a naturally occurring platelet-activating factor (PAF) receptor antagonist - on anaphylactic shock in rats |
| Q35202866 | Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis |
| Q28379513 | Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor |
Search more.